Literature DB >> 12637487

Role of DNA mismatch repair defects in the pathogenesis of human cancer.

Päivi Peltomäki1.   

Abstract

The DNA mismatch repair (MMR) system is necessary for the maintenance of genomic stability. In a broad sense, all main functions of the MMR system, including the correction of biosynthetic errors, DNA damage surveillance, and prevention of recombination between nonidentical sequences serve this important purpose. Failure to accomplish these functions may lead to cancer. It is therefore not surprising that inherited defects in the MMR system underlie one of the most prevalent cancer syndromes in humans, hereditary nonpolyposis colon cancer (HNPCC). In addition, acquired defects of the same system may account for 15% to 25%, or even a higher percentage, of sporadic cancers of different organs of the "HNPCC spectrum," including the colon and rectum, uterine endometrium, stomach, and ovaries. Recent studies indicate that the MMR genes may be involved in the pathogenesis of even a broader spectrum of tumors in one way or another. An updated review of the different features of the human MMR system will be provided, with the emphasis on their implications in cancer development.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12637487     DOI: 10.1200/JCO.2003.04.060

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  234 in total

1.  Microsatellite instability testing in Korean patients with colorectal cancer.

Authors:  Jung Ryul Oh; Duck-Woo Kim; Hye Seung Lee; Hee Eun Lee; Sung Min Lee; Je-Ho Jang; Sung-Bum Kang; Ja-Lok Ku; Seung-Yong Jeong; Jae-Gahb Park
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

Review 2.  Biomarkers and molecular diagnosis of gastrointestinal and pancreatic neoplasms.

Authors:  Shelby D Melton; Robert M Genta; Rhonda F Souza
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-10-05       Impact factor: 46.802

3.  Structure of the MutL C-terminal domain: a model of intact MutL and its roles in mismatch repair.

Authors:  Alba Guarné; Santiago Ramon-Maiques; Erika M Wolff; Rodolfo Ghirlando; Xiaojian Hu; Jeffrey H Miller; Wei Yang
Journal:  EMBO J       Date:  2004-10-07       Impact factor: 11.598

Review 4.  The utility of immunohistochemical detection of DNA mismatch repair gene proteins.

Authors:  Jinru Shia; Nathan A Ellis; David S Klimstra
Journal:  Virchows Arch       Date:  2004-09-29       Impact factor: 4.064

Review 5.  Poly(Adenosine diphosphate-ribose) polymerase inhibitors in cancer treatment.

Authors:  Sook Ryun Park; Alice Chen
Journal:  Hematol Oncol Clin North Am       Date:  2012-06       Impact factor: 3.722

6.  Constitutional mismatch repair-deficiency syndrome.

Authors:  Katharina Wimmer; Christian P Kratz
Journal:  Haematologica       Date:  2010-05       Impact factor: 9.941

7.  Association between monoallelic MUTYH mutation and colorectal cancer risk: a meta-regression analysis.

Authors:  Aung Ko Win; John L Hopper; Mark A Jenkins
Journal:  Fam Cancer       Date:  2011-03       Impact factor: 2.375

8.  Poly(ADP-ribose) polymerase inhibitors combined with external beam and radioimmunotherapy to treat aggressive lymphoma.

Authors:  Niklaus G Schaefer; Engles James; Richard L Wahl
Journal:  Nucl Med Commun       Date:  2011-11       Impact factor: 1.690

Review 9.  Hereditary nonpolyposis colorectal cancer (Lynch syndrome): criteria for identification and management.

Authors:  Gregory Kouraklis; Evangelos P Misiakos
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

10.  A genomewide screen in Saccharomyces cerevisiae for genes that suppress the accumulation of mutations.

Authors:  Meng-Er Huang; Anne-Gaelle Rio; Alain Nicolas; Richard D Kolodner
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.